Authors:
KROOK A
ALBERT J
ANDERSSON S
BIBERFELD G
BLOMBERG J
EKLUND I
ENGSTROM A
JULANDER I
KALL K
MARTIN C
STENDAHL P
STRUVE J
SONNERBORG A
Citation: A. Krook et al., PREVALENCE AND RISK-FACTORS FOR HTLV-II INFECTION IN 913 INJECTING DRUG-USERS IN STOCKHOLM, 1994, Journal of acquired immune deficiency syndromes and human retrovirology, 15(5), 1997, pp. 381-386
Authors:
ANDERSSON S
AHMED R
BREDBERGRADEN U
ALBERT J
KROOK A
KALL K
BIBERFELD G
POPOVIC M
Citation: S. Andersson et al., HTLV-II INFECTED SWEDISH INTRAVENOUS-DRUG-USERS CARRY SUBTYPE-A, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 266-266
Authors:
KROOK A
ALBERT J
ANDERSSON S
ENGSTRAND A
JULANDER I
KALL K
STENDAHL P
STRUVE J
SONNERBORG A
Citation: A. Krook et al., HUMAN T-LYMPHOTROPIC VIRUS TYPE-II AMONG INJECTING DRUG-USERS IN STOCKHOLM 1994, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 267-267
Citation: K. Kall et A. Nilsonne, PREFERENCE FOR SEX ON AMPHETAMINE - A MARKER FOR HIV RISK BEHAVIOR AMONG MALE INTRAVENOUS AMPHETAMINE USERS IN STOCKHOLM, AIDS care, 7(2), 1995, pp. 171-188
Authors:
ANDERSSON S
KROOK A
KALL K
JULANDER I
THORSTENSSON R
BIBERFELD G
Citation: S. Andersson et al., HTLV INFECTIONS AMONG SWEDISH INTRAVENOUS-DRUG-USERS IN 1992, Scandinavian journal of infectious diseases, 27(6), 1995, pp. 547-550
Citation: K. Kall, THE RISK OF HIV-INFECTION FOR NONINJECTING SEX PARTNERS OF INJECTING DRUG-USERS IN STOCKHOLM, AIDS education and prevention, 6(4), 1994, pp. 351-364